STAC

Sangamo Therapeutics to Present Neurology-Focused Pre-Clinical Data From Its Epigenetic Regulation, Capsid Delivery and Genome Engineering Platforms at the 27th Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT)

Retrieved on: 
Monday, April 22, 2024

Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, today announced that the American Society of Gene & Cell Therapy (ASGCT) has accepted 20 Sangamo abstracts for presentation at the 27th ASGCT Annual Meeting being held May 7-11, 2024, in-person in Baltimore, MD and in a virtual format.

Key Points: 
  • Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, today announced that the American Society of Gene & Cell Therapy (ASGCT) has accepted 20 Sangamo abstracts for presentation at the 27th ASGCT Annual Meeting being held May 7-11, 2024, in-person in Baltimore, MD and in a virtual format.
  • Presentations will focus on the progression of Sangamo’s neurology-focused pre-clinical pipeline, including data supporting innovations in zinc finger epigenetic regulation, advances in AAV capsid engineering, and discovery of next-generation integrase technology.
  • These data will showcase a novel AAV capsid, STAC-BBB, that exhibited robust and widespread central nervous system transduction in cynomolgus macaques after intravenous delivery, as well as another novel AAV capsid, STAC-150, engineered to accelerate the discovery of potent and highly specific epigenetic regulators.
  • Sangamo will also present additional data from its AAV capsid engineering platform SIFTER and its efforts for integrase evolution and utilization.

Philadelphia Phillies and NEST launch Skilled Trades All-Star Program to Ignite Interest in Skilled Trades Among Youth

Retrieved on: 
Thursday, April 18, 2024

PHILADELPHIA, April 18, 2024 /PRNewswire/ -- The Philadelphia Phillies and NEST, the pioneer of integrated facilities management, are joining forces to launch the Skilled Trades All-Star Program, a dynamic initiative aimed at guiding Philadelphia-area youth towards promising careers in the skilled trades. The initiative kicks off with a series of educational events at Citizens Bank Park this season.

Key Points: 
  • PHILADELPHIA, April 18, 2024 /PRNewswire/ -- The Philadelphia Phillies and NEST, the pioneer of integrated facilities management, are joining forces to launch the Skilled Trades All-Star Program, a dynamic initiative aimed at guiding Philadelphia-area youth towards promising careers in the skilled trades.
  • "The Skilled Trades All-Star Program isn't just about a single day at the ballpark; it's about sparking a lifelong interest in the trades that build and sustain our communities.
  • The Skilled Trades All-Star Program is a direct extension of STAC's mission, seeking to illuminate the path for youth toward these essential roles.
  • "Rejuvenating the skilled trades has been a priority for us at NEST and the founding members of the Skilled Trades Advisory Council, and we are making incredible progress," said Rob Almond, CEO of NEST.

Sangamo Therapeutics Reports Recent Business Highlights and Fourth Quarter and Full Year 2023 Financial Results

Retrieved on: 
Wednesday, March 13, 2024

Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicines company, today reported recent business highlights and fourth quarter and full year 2023 financial results, including meaningful data to support advancement of its neurology pipeline.

Key Points: 
  • Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicines company, today reported recent business highlights and fourth quarter and full year 2023 financial results, including meaningful data to support advancement of its neurology pipeline.
  • “In 2023, Sangamo announced the prioritization of its pipeline programs that support our focus as a neurology-focused genomic medicine company,” said Sandy Macrae, Chief Executive Officer of Sangamo.
  • STAC-BBB was well tolerated in NHPs, with no notable treatment related pathological findings in brain, spinal cord or peripheral tissues.
  • Revenues for the fourth quarter ended December 31, 2023 were $2.0 million, compared to $27.2 million for the same period in 2022.

Sangamo Therapeutics Announces Data From Novel Proprietary Neurotropic AAV Capsid Demonstrating Industry-leading Blood-brain Barrier Penetration and Brain Transduction in NHPs

Retrieved on: 
Wednesday, March 13, 2024

Sangamo is exploring avenues to resume development of these programs internally, subject to receipt of adequate funding, or with new potential collaborators.

Key Points: 
  • Sangamo is exploring avenues to resume development of these programs internally, subject to receipt of adequate funding, or with new potential collaborators.
  • In NHP studies when administered intravenously at clinically relevant doses, STAC-BBB demonstrated its potential to be a leading neurotropic capsid.
  • Exhibited 700-fold higher transgene expression in neurons compared to the benchmark capsid AAV9 and outperformed all other known published neurotropic capsid variants evaluated in the study.
  • STAC-BBB was well tolerated in NHPs, with no notable treatment related pathological findings in brain, spinal cord or peripheral tissues.

Saint Joseph's University to Induct NEST CEO Rob Almond into Haub School of Business Hall of Fame

Retrieved on: 
Wednesday, March 20, 2024

PHILADELPHIA, March 20, 2024 /PRNewswire/ -- Saint Joseph's University announced the induction of Rob Almond, Jr., MBA '04, CEO of NEST, into the Haub School of Business Hall of Fame. As the youngest person to ever receive the honor, Almond has demonstrated exceptional leadership and innovation as Chief Executive Officer of NEST, a leading provider of Integrated Facilities Management solutions for national retailers and multi-site businesses.

Key Points: 
  • PHILADELPHIA, March 20, 2024 /PRNewswire/ -- Saint Joseph's University announced the induction of Rob Almond, Jr., MBA '04, CEO of NEST, into the Haub School of Business Hall of Fame.
  • For over 30 years, the Erivan K. Haub School of Business at Saint Joseph's University has honored corporate citizens for their excellence in business management, entrepreneurship, and ingenuity.
  • Almond exemplifies what it means to be a Hall of Famer, achieving success in business, and having a positive and tangible impact on society.
  • Rob holds an undergraduate degree from the University of North Carolina at Greensboro, where he is now a Board Member for the Bryan School of Business.

Former EUROfusion CEO, Tony Donné, to Chair General Fusion’s Science and Technology Advisory Committee

Retrieved on: 
Wednesday, February 28, 2024

RICHMOND, British Columbia, Feb. 28, 2024 (GLOBE NEWSWIRE) -- Today, General Fusion announced the appointment of Tony Donné as Chair of its Science and Technology Advisory Committee (STAC).

Key Points: 
  • RICHMOND, British Columbia, Feb. 28, 2024 (GLOBE NEWSWIRE) -- Today, General Fusion announced the appointment of Tony Donné as Chair of its Science and Technology Advisory Committee (STAC).
  • Prior to EUROfusion, Tony was head of the Fusion Physics Division at DIFFER and Director of the ITER-Netherlands program.
  • “General Fusion’s deeply engaged Science and Technology Advisory Committee is one of our biggest assets,” said Greg Twinney, CEO, General Fusion.
  • General Fusion Science and Technology Advisory Committee members:
    Tony Donné, Ph.D., Chair of General Fusion’s STAC and the former CEO of EUROfusion.

Turbocharging the Engine: KX Unleashes AI-First Transformation with kdb+

Retrieved on: 
Wednesday, February 28, 2024

“For three decades, kdb+ has been at the core of our innovation, empowering the transformation of data into actionable insights.

Key Points: 
  • “For three decades, kdb+ has been at the core of our innovation, empowering the transformation of data into actionable insights.
  • This new version of kdb+ reaffirms our commitment to delivering simplicity, performance, and efficiency across the KX product suite, driving forward the AI-first ambitions of global organizations.
  • The latest enhancements to kdb+ are designed to efficiently manage and analyze the vast datasets needed for generative AI with unparalleled efficiency and scalability.
  • Customers will realize significantly faster data ingestion rates, enhanced query execution speeds, and a marked decrease in storage expenditure.

UP42 and GLOBHE Sign Partnership to Bring Drone Data to Geospatial Marketplace

Retrieved on: 
Wednesday, November 8, 2023

BERLIN, Nov. 8, 2023 /PRNewswire/ -- UP42, a leading geospatial developer platform and marketplace, and GLOBHE, the world's premier on-demand drone data marketplace, announced their partnership to make high-quality drone data available through UP42. The agreement expands UP42's current offer of satellite, aerial, elevation, weather, AIS and RF data

Key Points: 
  • Customers can now task drones and browse drone data next to other types of imagery, all in one place
    BERLIN, Nov. 8, 2023 /PRNewswire/ -- UP42, a leading geospatial developer platform and marketplace, and GLOBHE, the world's premier on-demand drone data marketplace, announced their partnership to make high-quality drone data available through UP42.
  • "We are incredibly excited to partner with UP42, an organization that, like GLOBHE, is at the forefront of geospatial innovation.
  • Drone data is a complementary remote-sensing tool for satellites, airplanes or helicopters, which enriches the aerial data collection methods on the UP42 marketplace.
  • To learn more about GLOBHE's drone data and place your first order through UP42, please visit https://up42.com/marketplace/data/tasking/globhe-tasking and https://up42.com/marketplace/data/archive/globhe .

UP42 and GLOBHE Sign Partnership to Bring Drone Data to Geospatial Marketplace

Retrieved on: 
Wednesday, November 8, 2023

BERLIN, Nov. 8, 2023 /PRNewswire/ -- UP42, a leading geospatial developer platform and marketplace, and GLOBHE, the world's premier on-demand drone data marketplace, announced their partnership to make high-quality drone data available through UP42. The agreement expands UP42's current offer of satellite, aerial, elevation, weather, AIS and RF data

Key Points: 
  • Customers can now task drones and browse drone data next to other types of imagery, all in one place
    BERLIN, Nov. 8, 2023 /PRNewswire/ -- UP42, a leading geospatial developer platform and marketplace, and GLOBHE, the world's premier on-demand drone data marketplace, announced their partnership to make high-quality drone data available through UP42.
  • "We are incredibly excited to partner with UP42, an organization that, like GLOBHE, is at the forefront of geospatial innovation.
  • Drone data is a complementary remote-sensing tool for satellites, airplanes or helicopters, which enriches the aerial data collection methods on the UP42 marketplace.
  • To learn more about GLOBHE's drone data and place your first order through UP42, please visit https://up42.com/marketplace/data/tasking/globhe-tasking and https://up42.com/marketplace/data/archive/globhe .

The Inner Circle Acknowledges, Elizabeth Weyerman as a Top Pinnacle Professional for her contributions to the field of Law

Retrieved on: 
Monday, September 18, 2023

TRUSSVILLE, Ala., Sept. 18, 2023 /PRNewswire/ -- Prominently featured in The Inner Circle, Elizabeth Weyerman is acknowledged as a Top Pinnacle Professional for her contributions to the field of Law.

Key Points: 
  • TRUSSVILLE, Ala., Sept. 18, 2023 /PRNewswire/ -- Prominently featured in The Inner Circle, Elizabeth Weyerman is acknowledged as a Top Pinnacle Professional for her contributions to the field of Law.
  • She has continued to pursue further education by earning various certifications as well as a Doctor of Jurisprudence from Samford University's Cumberland School of Law.
  • Touting more than three years in the field, Ms. Elizabeth Weyerman is an associate attorney with Beasley, Allen, Crow, Methvin, Portis & Miles, P.C., and specializes in toxic tort representation.
  • Excelling at her specialty, she has represented a variety of plaintiffs in Camp Lejeune; personal injury; and water pollution cases.